BPC-157 5 mg / TB-500 5 mg (Blend) by Dragon Pharma
What Is the BPC-157 / TB-500 Blend?
This Dragon Pharma vial combines two of the most researched recovery peptides in one lyophilized blend: 5 mg of BPC-157 and 5 mg of TB-500. BPC-157 is known for local tissue repair - tendons, ligaments, joints - while TB-500 (thymosin beta-4 fragment) is researched for systemic recovery and blood flow support.
In sports research the pair is a classic: one for the injury site, one for the whole system. The blend removes the need to reconstitute and dose two separate vials - one mix, one protocol.
BPC-157 / TB-500 Blend Research Use
The blend is reconstituted like any lyophilized peptide and dosed once daily in defined research blocks.
- Reconstitute the 5 mg + 5 mg vial with 1-2 mL bacteriostatic water.
- Daily dosing - subcutaneous, standard research practice.
- Defined blocks - typical research cycles run a few weeks with breaks between.
- One protocol - both peptides are delivered together, so a single daily injection covers the stack.
BPC-157 / TB-500 Blend Stacks
The blend already is the stack. Around it, research protocols add support products from the same Dragon Pharma line:
| Reference stack | Role |
|---|---|
| Bacteriostatic water | Solvent for reconstitution |
| BPC 157 | Standalone local-repair research runs |
| AOD 9604 5 mg | Fat metabolism research alongside recovery |
BPC-157 / TB-500 Blend Side Effects
Both peptides are generally regarded as well tolerated in research settings. The usual research-compound caveats apply.
- Research-only - limited formal human data.
- Injection site - mild local reaction possible, standard for subcutaneous peptides.
- Handling - reconstitute with bacteriostatic water, store cold, do not shake.
- Blood flow note - TB-500 research mentions angiogenesis; keep protocols to defined blocks.
This product is sold for research purposes only. It is not approved for human use and does not replace medical advice or local laws.
-
At first I honestly thought this wasn’t doing anything. First week — no changes, second week — still dealing with the same joint pain and recovery felt slow. I almost stopped using it thinking it was a waste. But around week 3 everything started to change. Less soreness, joints felt way better, and I could train hard again without that constant irritation. By week 4 recovery was on another level. Looking back, glad I didn’t quit early — this combo turned out to be incredible.
-
Used it for recovery support and really liked it. Less inflammation and my body feels more “put together” after training. Very smooth overall, no issues.
-
Solid blend. Helps with healing and I can train more consistently without nagging pain. Definitely something worth keeping in a cycle for recovery.
What is the BPC-157 / TB-500 blend?
It is a Dragon Pharma lyophilized research vial with 5 mg of BPC-157 and 5 mg of TB-500 combined. BPC-157 is researched for local tissue repair; TB-500 is researched for systemic recovery - one vial covers both.
What does TB-500 do?
TB-500 - a thymosin beta-4 fragment - is researched for systemic recovery: blood flow support and healing across the body, in contrast to BPC-157's local tissue focus.
Why take BPC 157 and TB-500 together?
The two cover different ends of recovery research - BPC-157 at the injury site, TB-500 body-wide. Combining them in one protocol is a classic sports-research approach, and the blend makes dosing simple.
How do I reconstitute the blend?
Reconstitute the 5 mg + 5 mg vial with 1-2 mL of bacteriostatic water, swirl gently - never shake - and store cold. Standard lyophilized peptide handling applies.
How much of the blend should I take?
With the vial mixed in 1-2 mL, dose by peptide weight per day in defined research blocks. Typical protocols reference a few hundred mcg of each peptide daily for a few weeks, then a break.
How long can I run the blend?
Research protocols typically run a few weeks - commonly 3-6 - followed by a break. Both peptides are meant for defined cycles, not permanent use.
Does the blend have side effects?
Both peptides are generally regarded as well tolerated in research settings. Mild injection-site reactions are possible. TB-500 research mentions blood vessel growth, so defined cycles are the responsible approach.
Is the Dragon Pharma blend legit?
Dragon Pharma products are manufactured under controlled conditions and third-party lab tested per batch. Check the batch number on your pack against the published lab report.
Related Products
